ArticleNeuro-oncology advances

Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.

Crismita Dmello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.